Tailoring breast cancer treatment to genetic status: The challenges ahead

Journal of Clinical Oncology

Volumn 22, Issue 10, 2004, Pages 1776-1777

  Daly, Mary B ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CANCER THERAPY; EDITORIAL; GENE MUTATION; GENETIC COUNSELING; GENETICS; GENOMIC INSTABILITY; HUMAN; OVARY CANCER; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; BREAST TUMOR; DECISION MAKING; FEMALE; NOTE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; HUMANS;

EID: 3042745491     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.02.994     Document Type: Editorial

References (14)

1. Collins FS: Shattuck lecture: Medical and societal consequences of the Human Genome Project. N Engl J Med 341:28-37, 1999
2. Streuwing JP, Hartge P, Wacholder S, et al: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408, 1997
3. Croyle RT, Achilles JS, Lerman C: Psychologic aspects of cancer genetic testing. Cancer 80:569-575, 1997
4. Randall J, Butow P, Kirk J, et al: Psychological impact of genetic counseling and testing in women previously diagnosed with breast cancer. Intern Med J 31:397-405, 2001
5. Schwartz MD, Peshkin BIM, Hughes C, et al: Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20:514-520, 2002
6. Hartmann LC, Sellers TA, Schaid DJ, et al: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 93:1633-1637, 2001
7. Rebbeck TR, Lynch HT, Neuhausen SL, et al: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622, 2002
8. Kauf ND, Satagopan JM, Robson ME, et al: Risk-reducing salpingooophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615, 2002
9. Verhoog LC, Brekelmans CT, Seynaeve C, et al: Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 17:3653-3663, 1999
10. Pierce LJ, Strawderman M, Narod SA, et al: Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18:3360-3369, 2000
11. Robson M, Levin D, Federici M, et al: Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA founder mutations. J Natl Cancer Inst 91:2112-2117, 1999
12. Greene MH: Genetics of breast cancer. Mayo Clin Proc 72:54-65, 1997
13. Schwartz MD, Lerman C, Brogan B, et al: Impact of BRCA1/BRCA2 counseling and testing in newly diagnosed breast cancer patients. J Clin Oncol 22:1823-1829, 2004
14. Lerman C, Schwartz M, Lin T, et al: The influence of psychological distress on use of genetic testing for cancer risk. J Consult Clin Psychol 65:414-420, 1997